Telo Genomics Corp.

Research Telo Genomics Corp. (TELO.V) on Bullrun: market cap CAD 5.02M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is CAD 5.02M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CAD 0-CAD 2.62M-CAD 2.20Mn/an/aCAD 50.11KCAD 161.31K-CAD 553.33K

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-26CAD 5.02Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 CAD.

About Telo Genomics Corp.

Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The company's TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability, identify specific disease mechanisms, predict disease risks, and determine effective treatments.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Telo Genomics Corp.'s market cap?

Telo Genomics Corp.'s market capitalization is CAD 5.02M.

What does Telo Genomics Corp. do?

Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The company's TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability, identify specific disease mechanisms, predict disease risks, and determine effective treatments.